Brand-name GLP-1 medications list for a lot. As of mid-2026, the sticker price for drugs like Wegovy or Zepbound runs about $1,000 to $1,300 a month before any help. Here's the good news: almost nobody pays that. The list price is a starting point, not the final number. Once you know the levers, you can often cut it by more than half.
Manufacturer Savings Cards
If you have commercial insurance (a plan through work or one you buy yourself) that covers the drug, a savings card is your best first move. With one, Wegovy, Zepbound, Ozempic, and Mounjaro can run as little as $25 a month. Novo Nordisk makes Wegovy and Ozempic. Eli Lilly makes Zepbound and Mounjaro. Both run these programs.
The catch: savings cards usually don't work with government plans like Medicare, Medicaid, or Tricare, and they can have yearly caps. Ask your clinic to help you enroll. Many do it as part of onboarding. Our savings calculator can show you roughly what you'd pay.
Buy Direct From the Maker, No Insurance Needed
No coverage? Both makers now sell straight to patients, which skips the retail pharmacy markup.
- Wegovy through NovoCare: $349 a month for the pens, $399 for Wegovy HD, or from $149 for the pill. A $199 intro rate on your first two pen fills runs through the end of 2026.
- Zepbound through LillyDirect: $299 to $449 a month depending on dose. Holding the $449 price on the higher doses means refilling within 45 days.
- Mounjaro through LillyDirect: listed, but Lilly has not published a settled self-pay price for it. Ask LillyDirect for a quote.
Compare that to the $1,000-plus list price and the savings are clear. For more on how these drugs stack up, see our semaglutide guide and tirzepatide guide.
A Note on Compounded Versions
During the 2023 and 2024 shortage, compounding pharmacies sold semaglutide and tirzepatide for roughly $150 to $500 a month, and many people leaned on them to save. That window has closed. The FDA ended its shortage allowances in early 2025 and proposed a permanent ban in April 2026. As of mid-2026, cheap compounded GLP-1s are no longer a broadly legal or reliable option. If you were counting on them, shift to the legitimate paths above. Our compounded vs brand-name breakdown explains what changed.
Insurance and Prior Authorization
If your plan might cover a GLP-1, it's worth the paperwork. Many plans require prior authorization, which means your doctor has to document why you need the drug before the plan pays. Denials are common, and so are reversals. If you get denied, appeal it. A letter from your doctor with your weight history and health conditions often turns a no into a yes. Our guide to whether insurance covers GLP-1s walks through the steps.
New in 2026: Medicare Coverage
Since July 1, 2026, Medicare Part D covers Wegovy and Zepbound for obesity at a $50 monthly copay for people who qualify. This is a real shift for older adults who were priced out before. See our full write-up on Medicare GLP-1 coverage to check if you're eligible.
A Few More Ways to Save
- Patient assistance programs: both makers offer income-based programs for people without coverage. If you qualify, the cost can drop to very little or nothing.
- Clinical trials: some research studies provide the medication at no cost. Ask your doctor or search trial registries.
- Cash-pay clinics with clear pricing: clinic prices vary a lot, and there's little pressure to be upfront. Call at least three providers and ask for the total monthly cost, including the drug, visits, and labs, before you commit.
Pricing changes fast, so compare options for your exact plan and dose. And talk to your doctor about which route fits your health and budget.
Find an Affordable Clinic Near You
Ready to compare real prices? Use our clinic directory to find GLP-1 providers in your area, filter by medication, and check which ones offer telehealth. Browse clinics by state, or scan telehealth programs that ship nationwide. Contact your top few for a total monthly quote, then pick the one that's honest about cost.